Filing Details
- Accession Number:
- 0001645627-18-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-06 16:41:34
- Reporting Period:
- 2018-11-29
- Accepted Time:
- 2018-12-06 16:41:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Transaction Summary
| Purchased: | 34,100 shares | Avg. Price: $0.03 | Total Value: $963.80 |
| Number of Shares After Transactions: | 26,287,098 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-29 | 2,000 | $0.03 | 26,254,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-29 | 2,000 | $0.03 | 26,256,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-29 | 2,000 | $0.03 | 26,258,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 2,000 | $0.03 | 26,260,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 2,000 | $0.03 | 26,262,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 100 | $0.03 | 26,263,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 1,000 | $0.03 | 26,264,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 1,000 | $0.03 | 26,265,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 2,000 | $0.03 | 26,267,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 2,000 | $0.03 | 26,269,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 1,000 | $0.03 | 26,270,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 1,000 | $0.03 | 26,271,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 1,000 | $0.03 | 26,272,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 1,000 | $0.03 | 26,273,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,275,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,277,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,279,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,281,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,283,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,285,098 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-03 | 2,000 | $0.03 | 26,287,098 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
